Budesonide Novolizer Dry Powder Inhaler 200 μg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Budesonide Novolizer Dry Powder Inhaler 200 μg, covering 2011-08-23 to 2011-08-23. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma [Phase 2, Phase 3]